Systemic Cardiac Amyloidoses: Disease Profiles and Clinical Courses of the 3 Main Types

By C. Rapezzi, G. Merlini, C. Quarta, L. Riva, S. Longhi, O. Leone, F. Salvi, P. Ciliberti, F. Pastorelli, E. Biagini and 14 more. Circulation, 2009

711 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Molecular Biology

View Paper: https://www.semanticscholar.org/paper/0867a012e72aa578050d7cfbcba31f618b0488fd

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. J. Berk
2. Y. Ando
3. T. Coelho
4. M. Waddington Cruz
5. B. Ericzon
6. L. Obici
7. V. Planté-Bordeneuve
8. S. Ikeda

Citations in the corpus

• Guideline of transthyretin-related hereditary amyloidosis for clinicians (2013, background): “5 mV in all limb leads or ≤1 mV in all precordial leads) usually is significantly lower in patients with TTR amyloidosis than in patients with AL [70].”